Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study

In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-12, Vol.15 (12), p.e0244242-e0244242
Hauptverfasser: Muwonge, Richard, Basu, Partha, Gheit, Tarik, Anantharaman, Devasena, Verma, Yogesh, Bhatla, Neerja, Joshi, Smita, Esmy, Pulikottil O, Poli, Usha Rani Reddy, Shah, Anand, Zomawia, Eric, Shastri, Surendra S, Pimple, Sharmila, Prabhu, Priya R, Hingmire, Sanjay, Chiwate, Aruna, Sauvaget, Catherine, Lucas, Eric, Malvi, Sylla G, Siddiqi, Maqsood, Sankaran, Subha, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Divate, Uma, Vashist, Shachi, Mishra, Gauravi, Jadhav, Radhika, Tommasino, Massimo, Pillai, M Radhakrishna, Sankaranarayanan, Rengaswamy, Jayant, Kasturi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0244242